Literature DB >> 19152411

Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.

Wei-Sheng Wang1, Moon-Sing Lee, Chih-En Tseng, I-Huan Liao, Shu-Ping Huang, Ru-Inn Lin, Chin Li.   

Abstract

The E2 protein of the papillomavirus plays an essential role in the viral life cycle. Through a yeast two-hybrid screening, human polo-like kinase 1 was found to interact with human papillomavirus type 5 E2. Further characterization identified that the domains responsible for the interaction are the transactivation domain of HPV-5 E2 and the sequence between the kinase and the polo box domains of Plk1. In vivo, Plk1 and HPV-5 E2 are colocalized at the nuclear speckles. In the skin epithelium not infected with epidermodysplasia verruciformis associated HPVs, Plk1 is expressed in the stratum basale, indicating that the Plk1-HPV-5 E2 interaction likely occurs in the keratinocytes at the basal layer of the epithelium upon infection of HPV-5. Both HPV-5 E2 and Plk1 also interact with the E2 binding domain of Brd4. The E2 binding domain of Brd4 is phosphorylated by Plk1 in vitro, and this phosphorylation event is blocked by the presence of HPV-5 E2. Hence, these findings suggest the possibility that the cellular function of Brd4 is de-regulated by forming a complex with HPV-5 E2 in the infected epithelial cells. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152411     DOI: 10.1002/jmv.21404

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups.

Authors:  Moon Kyoo Jang; D Eric Anderson; Koenraad van Doorslaer; Alison A McBride
Journal:  Proteomics       Date:  2015-04-28       Impact factor: 3.984

2.  Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

Authors:  Sophie Bellanger; Chye Ling Tan; Yue Zhen Xue; Sébastien Teissier; Françoise Thierry
Journal:  Am J Cancer Res       Date:  2011-01-24       Impact factor: 6.166

3.  Kinase Activity of Fibroblast Growth Factor Receptor 3 Regulates Activity of the Papillomavirus E2 Protein.

Authors:  Fang Xie; Marsha DeSmet; Sriramana Kanginakudru; Leny Jose; Sara P Culleton; Timra Gilson; Chengxin Li; Elliot J Androphy
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

4.  Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2.

Authors:  Emma L Prescott; Claire L Brimacombe; Margaret Hartley; Ian Bell; Sheila Graham; Sally Roberts
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

5.  The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network.

Authors:  Mandy Muller; Caroline Demeret
Journal:  Open Virol J       Date:  2012-12-28

6.  Polo-like kinase 1 inhibits the activity of positive transcription elongation factor of RNA Pol II b (P-TEFb).

Authors:  Liangzhen Jiang; Yan Huang; Min Deng; Ting Liu; Wenbin Lai; Xin Ye
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

7.  Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.

Authors:  Irena Zurnic; Sylvia Hütter; Ute Rzeha; Nicole Stanke; Juliane Reh; Erik Müllers; Martin V Hamann; Tobias Kern; Gesche K Gerresheim; Fabian Lindel; Erik Serrao; Paul Lesbats; Alan N Engelman; Peter Cherepanov; Dirk Lindemann
Journal:  PLoS Pathog       Date:  2016-08-31       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.